The whole ‘who survives the FDA compounding crackdown’ conversation is mostly noise to me. What I keep thinking about is the metabolic window that’s opening up for a lot of people whether they want it or not. If you’ve been on compounded tirz for 8+ months and your source dries up, that’s a forced washout. Most people are scrambling for a replacement pharmacy. That’s understandable, but if you care about your actual data, the gap is worth something. Useful thing to do while the shelf is empty: get labs. Fasting glucose, fasting insulin, HbA1c if it’s been a while, full lipid panel. Compare against your on-protocol numbers. The delta between those two readings tells you something your titration log can’t - how much of your metabolic improvement was active compound versus behavioral habits that locked in along the way. A lot of people assume it’s 90% the drug. Some will be surprised. I’ve been logging fasting glucose long enough in CareClinic that the trend lines made it obvious when a real shift happened versus noise. Same principle applies here - you need a before, a during, and an after to actually learn anything. The supply chaos is real and frustrating. But involuntary gaps have signal if you’re set up to read them. Most people aren’t, which is why they won’t.
the before/during/after framing is the right instinct and I’d second it, especially for anyone who’s been treating their titration log as if it told the whole story. where I’d push gently is on the timing of the “after” draw, because there are two clocks running through that gap and they’re not the same one. tirz half-life is roughly five days, so meaningful clearance takes the better part of a month, and hepatic insulin sensitivity doesn’t snap back the instant the drug is gone either, it tracks liver fat which lags. a fasting insulin pulled at week 2 of a gap is reading a very different physiology than one pulled at week 8, and people will draw conclusions about “behavioral lock-in” from numbers that are really just mid-washout. the other small flag: fasting insulin has a brutal intra-individual CV, so one draw isn’t really one data point. ideally two, a week apart. the free-text journal field next to each lab entry in CareClinic is what lets me reconstruct context months later, otherwise the numbers are just numbers.
eta: one more thing
There’s a third clock nobody’s flagged yet, and it shows up specifically in the lipid panel. During active fat mobilization - which continues well into the washout window even if you’re not actively restricting calories - free fatty acids cycling through the liver can produce a transient LDL-C bump that looks alarming if you don’t know to expect it. It’s the same phenomenon people occasionally see in the early weeks of aggressive caloric restriction: adipose releasing faster than the liver is clearing. If someone pulls a full lipid panel at week 3 of a gap and sees LDL higher than their on-protocol numbers, the reflex is to credit the drug with the improvement. Sometimes that’s accurate. But sometimes you’re catching liver traffic mid-clearance, not a genuine baseline. The more informative read tends to come 10-12 weeks out, once body composition has actually stabilized. eliza.g’s point about the two clocks for insulin applies here too - the lipid picture runs on its own schedule, separate from both fasting glucose and hepatic insulin sensitivity. Worth mentioning to your GP before they receive the panel results and start asking questions you’re not in a position to answer mid-gap. A quick note flagging the timing context can save a lot of unnecessary follow-up.
the LDL bump during active mobilization is a real and underdiscussed phenomenon, and the 10-12 week reread is the right call. one nuance I’d add to “transient LDL-C bump that looks alarming”: the panel isn’t just shifted up uniformly, the particle distribution skews too. ApoB and an NMR LipoProfile during that window will often tell a different story than the calculated LDL-C alone, because what’s cycling through is largely large-buoyant rather than small-dense. if someone’s GP is reflex-prescribing off a single LDL number mid-clearance without an ApoB to anchor it, that’s the actual avoidable mess. timing context note to the GP, agreed, fwiw.